Featured
Premium
Confidential Source•Jul 6, 2026
T2S Group Aims to Almost Double Revenue to DH4.2 bn by 2030 with Casablanca IPO
Read More
Market Insights
BOURSSOLE Newsroom
Stay ahead of the market with our curated AI-powered financial news and expert analysis.
5 results for “pharmaceutical”
Stocks Market
•September 25th, 2026Promopharm Issues Profit Warning: H1 2026 Net Income Plunges 74% Despite 9% Revenue Growth
Moroccan pharmaceutical laboratory Promopharm has warned investors of a sharp 74% year-on-year decline in net profit for the first half of 2026, estimating social net income at MAD 6.7 million versus MAD 26.2 million in H1 2025. The drop comes despite a solid 9% revenue increase to MAD 507 million, ...
Stocks Market
T2S Group Aims to Almost Double Revenue to DH4.2 bn by 2030 with Casablanca IPO
Premium
Confidential Source•Jul 6
Moroccan MedTech leader T2S Group Holding received approval from the Moroccan Capital Market Authority to launch an IPO on the Casablanca Stock Exchan...
Stocks Market
Morocco’s Manufacturing Output Slides 1.4% in Q1 2026, While Auto and Pharma Sectors Show Gains
boursenews.ma•Jun 15
The High Commission for Planning (HCP) reports that Morocco’s non‑oil‑refining manufacturing production index fell 1.4% in the first quarter of 2026 c...
Stocks Market
Sothema 2026 Strategy: Scaling Innovation and Global Expansion
Premium
Confidential Source•May 4
As it celebrates its 50th anniversary, Sothema is launching an ambitious strategic roadmap for 2026. The pharmaceutical leader aims to dominate the Mo...